What is LXEO's dilution risk score?

LXEO has a latest available DilutionScore record of 42/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for LXEO, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for LXEO?

DilutionWatch tracks 25 SEC filing types for LXEO including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect LXEO shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For LXEO, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for LXEO tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for LXEO. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

LXEO Dilution Risk Score: 42/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

60

💰 Cash Runway

10

📊 Float Risk

55

⚠️ Warrant Exposure

40

🔄 Convertible Debt

15

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for LXEO.

🔔 Track LXEO — Get forecast alerts →

Market Data

Market Cap$403.60M

Shares Outstanding82.05M

Float47.51M

Cash$163.75M

DebtN/A

Short InterestN/A

Institutional Holdings

QoQ: ↑ 22.3% shares (2026Q1 vs prior)

139 institutional holders · 95.42M shares

#1 JANUS HENDERSON GROUP PLC 9.95M shares

#2 Paradigm Biocapital Advisors LP 6.18M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 6.01M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest17.05M

Days to Cover16.9

% of Float35.9%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

xbrl XBRL CONVERTIBLE 2023-12-31

8-K 8K EVENT 2026-04-30

3 FORM3 2026-04-30

4 INSIDER TRANSACTION 2026-04-30

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual LXEO Dilution Snapshot

Lexeo Therapeutics, Inc. (LXEO) has a DilutionScore of 42/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for LXEO: xbrl on 2026-06-30; 8-K on 2026-04-30; 3 on 2026-04-30.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.